An arachidonic acid-enriched diet does not result in more colonic inflammation as compared with fish oil- or oleic acid-enriched diets in mice with experimental colitis

British Journal of Nutrition

Volumn 100, Issue 2, 2008, Pages 347-354

  Ramakers, Julian D ^a   Mensink, Ronald P ^a   Verstege, Marleen I ^b   Te Velde, Anje A ^b   Plat, Jogchum ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Arachidonic acid; Colitis; Dextran sodium sulfate; Fish oil; Oleic acid

Indexed keywords

ARACHIDONIC ACID; CYTOKINE; DEXTRAN SULFATE; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; MYELOPEROXIDASE; OLEIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; ENZYME BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; ORGAN WEIGHT; POLYMORPHONUCLEAR CELL; TISSUE HOMOGENATE; TREATMENT DURATION; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; ARACHIDONIC ACID; BODY WEIGHT; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DIET; DISEASE MODELS, ANIMAL; FATTY ACIDS; FEMALE; FISH OILS; FOOD ANALYSIS; MICE; MICE, INBRED C57BL; OLEIC ACID; ORGAN SIZE; PEROXIDASE; SERUM AMYLOID P-COMPONENT;

MUS;

EID: 52949134855     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507901257     Document Type: Article

References (46)

1. Belluzzi A (2002) n-3 Fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc 61, 391-395.
2. Nishida T, Miwa H, Shigematsu A, Yamamoto M, Iida M & Fujishima M (1987) Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut 28, 1002-1007.
3. Buhner S, Nagel E, Korber J, Vogelsang H, Linn T & Pichlmayr R (1994) Ileal and colonic fatty acid profiles in patients with active Crohn's disease. Gut 35, 1424-1428.
4. Pacheco S, Hillier K & Smith C (1987) Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease. Clin Sci (Lond) 73, 361-364.
5. Hawthorne AB, Daneshmend TK, Hawkey CJ, Belluzzi A, Everitt SJ, Holmes GK, Malkinson C, Shaheen MZ & Willars JE (1992) Treatment of ulcerative colitis with fish oil supplementation: A prospective 12 month randomised controlled trial. Gut 33, 922-928.
6. Ramakers JD, Mensink RP, Schaart G & Plat J (2007) Arachidonic acid but not eicosapertaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells. Lipids 42, 687-698.
7. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S & Miglioli M (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334, 1557-1560.
8. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL & Becken W (1992) Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116, 609-614.
9. Almallah YZ, El-Tahir A, Heys SD, Richardson S & Eremin O (2000) Distal procto-colitis and n-3 polyunsaturated fatty acids: The mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest 30, 58-65.
10. Salomon P, Kornbluth AA & Janowitz HD (1990) Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: An open trial. J Clin Gastroenterol 12, 157-161.
11. McCall TB, O'Leary D, Bloomfield J & O'Morain CA (1989) Therapeutic potential of fish oil in the treatment of ulcerative colitis. Aliment Pharmacol Ther 3, 415-424.
12. Lorenz-Meyer H, Bauer P, Nicolay C, Schulz B, Purmann J, Fleig WE, Scheurlen C, Koop I, Pudel V & Carr L (1996) Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). Scand J Gastroenterol 31, 778-785.
13. Loeschke K, Ueberschaer B, Pietsch A, Gruber E, Ewe K, Wiebecke B, Heldwein W & Lorenz R (1996) n-3 Fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 41, 2087-2094.
14. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T & Loeschke K (1989) Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease - a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl 731, 225-232.
15. Dichi I, Frenhane P, Dichi JB, Correa CR, Angeleli AY, Bicudo MH, Rodrigues MA, Victoria CR & Burini RC (2000) Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis. Nutrition 16, 87-90.
16. Aslan A & Triadafilopoulos G (1992) Fish oil fatty acid supplementation in active ulcerative colitis: A double-blind, placebo-controlled, crossover study. Am J Gastroenterol 87, 432-437.
17. Nieto N, Torres MI, Rios A & Gil A (2002) Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 132, 11-19.
18. Camuesco D, Galvez J, Nieto A, Comalada M, Rodriguez-Cabezas ME, Concha A, Xaus J & Zarzuelo A (2005) Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr 135, 687-694.
19. Empey LR, Jewell LD, Garg ML, Thomson AB, Clandinin MT & Fedorak RN (1991) Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. Can J Physiol Pharmacol 69, 480-487.
20. Yuceyar H, Ozutemiz O, Huseyinov A, Saruc M, Alkanat M, Bor S, Coker I & Batur Y (1999) Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats? Prostaglandins Leukot Essent Fatty Acids 61, 339-345.
21. Guarner F, Vilaseca J & Malagelada JR (1992) Dietary manipulation in experimental inflammatory bowel disease. Agents Actions Special Conference Issue, C10-C14.
22. Whiting CV, Bland PW & Tarlton JF (2005) Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis. Inflamm Bowel Dis 11, 340-349.
23. Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M & Malagelada JR (1990) Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 31, 539-544.
24. Tenikoff D, Murphy KJ, Le M, Howe PR & Howarth GS (2005) Lyprinol (stabilised lipid extract of New Zealand green-lipped mussel): A potential preventative treatment modality for inflammatory bowel disease. J Gastroenterol 40, 361-365.
25. Hegazi RA, Saad RS, Mady H, Matarese LE, O'Keefe S & Kandil HM (2006) Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-10 knockout mice. Nutrition 22, 275-282.
26. Wensing AG, Mensink RP & Hornstra G (1999) Effects of dietary n-3 polyunsaturated fatty acids from plant and marine origin on platelet aggregation in healthy elderly subjects. Br J Nutr 82, 183-191.
27. Bligh EG & Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
28. Kaluzny MA, Duncan LA, Merritt MV & Epps DE (1985) Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 26, 135-140.
29. Morrison WR & Smith LM (1964) Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5, 600-608.
30. Daemen MA, Heemskerk VH, van't Veer C, Denecker G, Wolfs TG, Vandenabeele P & Buurman WA (2000) Functional protection by acute phase proteins α(1)-acid glycoprotein and α(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation 102, 1420-1426.
31. Cooper HS, Murthy SN, Shah RS & Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69, 238-249.
32. Serhan CN (2005) Novel eicosanoid and docosanoid mediators: Resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care 8, 115-121.
33. Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, Rohrer J, Benninghoff AU & Hontecillas R (2004) Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127 777-791.
34. Whelan J, Surette ME, Hardardottir I, Lu G, Golemboski KA, Larsen E & Kinsella JE (1993) Dietary arachidonate enhances tissue arachidonate levels and eicosanoid production in Syrian hamsters. J Nutr 123 2174-2185.
35. Mohrhauer H & Holman RT (1963) The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver. J Lipid Res 4, 151-159.
36. Danon A, Heimberg M & Oates JA (1975) Enrichment of rat tissue lipids with fatty acids that are prostaglandin precursors. Biochim Biophys Acta 388, 318-330.
37. Leaf A & Weber PC (1988) Cardiovascular effects of n-3 fatty acids. N Engl J Med 318, 549-557.
38. Kinsella JE, Lokesh B, Broughton S & Whelan J (1990) Dietary polyunsaturated fatty acids and eicosanoids: Potential effects on the modulation of inflammatory and immune cells: An overview. Nutrition 6, 24-44; discussion 59-62.
39. Kwon KH, Murakami A, Tanaka T & Ohigashi H (2005) Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: Attenuation of pro-inflammatory gene expression. Biochem Pharmacol 69, 395-406.
40. Anonymous (2004) Suppressive activity of a fermented grain food product on dextran sulfate sodium-induced experimental colitis in mice. Biofactors 21, 179-184.
41. Liu C, Russell RM, Smith DE, Bronson RT, Milbury PE, Furukawa S, Wang XD & Blumberg JB (2004) The effect of dietary glutathione and coenzyme Q10 on the prevention and treatment of inflammatory bowel disease in mice. Int J Vitam Nutr Res 74, 74-85.
42. Micallef MJ, Iwaki K, Ishihara T, Ushio S, Aga M, Kunikata T, Koya-Mitaya S, Kimoto T, Ikeda M & Kurimoto M (2002) The natural plant product tryptanthrin ameliorates dextran sodium sulfate-induced colitis in mice. Int Immunopharmacol 2, 565-578.
43. Lawson LD & Hughes BG (1988) Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem Biophys Res Commun 152, 328-335.
44. Anonymous (1988) Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochem Biophys Res Commun 156, 960-963.
45. el Boustani S, Colette C, Monnier L, Descomps B, Crastes de Paulet A & Mendy F (1987) Enteral absorption in man of eicosapentaenoic acid in different chemical forms. Lipids 22, 711-714.
46. Anonymous (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 354, 447-455.